Cialis (Tadalafil): What People Actually Pay and Real-World Results

How Much Does Cialis Actually Cost in 2025?

The honest answer depends on three variables: brand vs. Generic, dose, and whether you use a discount program. Brand-name Cialis carries a list price around $420 for a 30-tablet supply of 20 mg tablets at most US retail pharmacies. Generic tadalafil, available since 2018, has driven the street price down by more than 90 percent for most patients.

Brand Cialis vs. Generic Tadalafil Pricing

The FDA approved generic tadalafil in September 2018, and competition among manufacturers quickly pushed prices to levels most men find manageable without insurance. GoodRx data consistently shows tadalafil 20 mg (6 tablets, the typical "on-demand" supply for one month) at $15 to $35 at CVS, Walgreens, and Walmart with a coupon. A 30-tablet supply for daily use runs $20 to $50 depending on the dose.

Cost Plus Drugs (Mark Cuban's pharmacy) lists tadalafil 5 mg at $12.60 for 30 tablets and 20 mg at $21.00 for 30 tablets as of early 2025, prices that represent the current floor for US patients.

What Insurance Actually Covers

Most commercial health plans exclude ED medications from their formularies under a "lifestyle drug" classification, though exceptions exist when tadalafil is prescribed for BPH. Medicare Part D similarly excludes ED medications but may cover tadalafil when the primary indication on the prescription is BPH or pulmonary arterial hypertension. Men using tadalafil specifically for BPH should ask their prescribing physician to list that diagnosis on the script, which can open coverage that would otherwise be denied.

Telehealth and Compounding Costs

Telehealth platforms now offer tadalafil subscriptions that bundle the physician visit and medication. Prices on these platforms typically range from $30 to $90 per month. Some compound pharmacies offer tadalafil in oral dissolving strips or troches at similar price points, though compounded versions are not FDA-approved finished drug products. The FDA's guidance on compounded drug products is clear that compounded preparations fall outside the standard approval pathway, which is worth knowing before substituting them for commercially manufactured generics.

What Clinical Trials Actually Show

User reviews gain context only when read alongside hard trial data. Tadalafil has one of the largest clinical evidence bases for any ED medication, with key studies conducted before and after its January 2003 FDA approval.

The Brock 2002 Key Trial

Brock et al. Published the defining dose-ranging study in the Journal of Urology in 2002. The trial enrolled men with mild-to-severe ED and tested tadalafil at 2 mg, 5 mg, 10 mg, and 20 mg against placebo. Brock et al., J Urol 2002 reported that tadalafil 20 mg produced a mean IIEF erectile function domain score of 22.5 compared to 13.0 for placebo (P<0.001). Successful intercourse attempts were reported in 75 percent of the tadalafil 20 mg group versus 32 percent in the placebo group. The 36-hour window of efficacy documented in this study became the central marketing claim for Cialis and the feature most cited by real users online.

Daily Dosing for BPH: What the Data Say

The FDA approved tadalafil 5 mg once daily for BPH in October 2011, based on data showing significant reductions in International Prostate Symptom Score (IPSS). A randomized controlled trial published in The Journal of Urology demonstrated that tadalafil 5 mg daily reduced IPSS by 5.0 points versus 2.3 points for placebo at 12 weeks (P<0.001), while simultaneously improving erectile function scores. This dual benefit drives the real-world preference for daily tadalafil among men over 50 with both conditions.

A systematic review and meta-analysis published via PubMed covering 14 randomized trials (N=4,847) confirmed that PDE5 inhibitors as a class meaningfully improved both IPSS and erectile function domain scores, with tadalafil showing the largest dataset among daily-dosed agents.

Tadalafil vs. Sildenafil: Head-to-Head Evidence

A crossover trial summarized in a PubMed-indexed review found that when men who had used both agents were asked to express preference, 63 percent preferred tadalafil and 37 percent preferred sildenafil. The dominant reasons cited were the longer window and the ability to take tadalafil without strict meal timing. Sildenafil absorption is reduced by high-fat meals; tadalafil is not affected by food. That pharmacokinetic difference shows up repeatedly in Reddit threads and review sites.

What Real Users Report: Reddit, Drugs.com, and PatientsLikeMe

Self-reported user data carries real limitations. Review aggregators attract men with strong opinions in either direction. Reddit threads are not random samples. PatientsLikeMe skews toward men managing chronic conditions. These caveats matter, and the patterns below should be read as directional signals rather than prevalence estimates.

Reddit: r/TRT, r/erectiledysfunction, and r/Cialis

The r/erectiledysfunction and r/TRT communities on Reddit contain thousands of tadalafil threads. Several recurring themes emerge across a non-systematic reading of posts from 2022 to 2025.

On cost: Users in r/TRT regularly report paying $12 to $20 per month for generic tadalafil 5 mg daily through Cost Plus Drugs or GoodRx, framing this as "the best value in men's health." A frequently upvoted comment from early 2024 stated: "I switched from brand Cialis to generic tadalafil 5mg daily and pay $18 a month now. Identical effect. The price difference is insane."

On the 36-hour window: The phrase "weekend pill" appears constantly. Men describe the benefit as removing performance anxiety related to timing. "You take it Friday night and you're fine through Sunday," is a representative summary of dozens of similar posts.

On side effects: Back pain and leg aches appear in roughly one in five posts mentioning side effects. Most describe them as mild and occurring 12 to 24 hours after the dose, consistent with clinical trial reports of myalgia in 5 to 6 percent of patients. A smaller subset reports nasal congestion and facial flushing, generally described as less severe than what they experienced with sildenafil.

Drugs.com: 1,400+ Reviews Analyzed

Drugs.com aggregates structured user reviews with a 1-to-10 rating scale. Tadalafil carries an average rating of 8.2 out of 10 across more than 1,400 reviews as of mid-2025. Positive reviews cluster around effectiveness and duration. Negative reviews most often cite headache, back pain, and, in a small minority, the medication not working at all, typically in men with severe vascular disease or those on nitrates (for whom tadalafil is contraindicated). FDA prescribing information for tadalafil lists nitrate co-administration as an absolute contraindication due to the risk of severe hypotension.

PatientsLikeMe Data Patterns

PatientsLikeMe users reporting tadalafil use tend to be older (median reported age mid-50s) and managing comorbidities including hypertension, diabetes, and BPH. Within this population, satisfaction with daily tadalafil 5 mg is high, with users citing improved urinary flow as an ancillary benefit. The selection bias here is meaningful: men who stay on PatientsLikeMe long enough to log outcomes are likely adherent users with positive experiences.

Who Should (and Should Not) Use Tadalafil

Tadalafil is a PDE5 inhibitor. It works by blocking phosphodiesterase type 5, which degrades cyclic GMP, the signaling molecule that relaxes smooth muscle in penile arteries and the prostate. The drug does not produce an erection without sexual stimulation. That distinction matters for managing expectations.

Appropriate Candidates

The American Urological Association guideline on ED recommends PDE5 inhibitors as first-line therapy for most men with ED. Tadalafil is appropriate for men with ED of psychogenic, vasculogenic, or mixed etiology, men with concurrent BPH, and men who prefer not to plan intercourse around a narrow dosing window. The 5 mg daily dose is particularly suitable for men having intercourse two or more times per week, since the steady-state plasma concentration achieved with daily dosing eliminates the need for on-demand timing.

Contraindications and Cautions

Tadalafil is absolutely contraindicated with any nitrate medication (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to additive hypotensive effects that can produce severe, life-threatening blood pressure drops. The FDA label also advises caution with alpha-blockers, where the combination can cause symptomatic hypotension, particularly with tamsulosin, though the interaction is less severe with tadalafil than sildenafil.

Men with severe hepatic impairment (Child-Pugh Class C) should not use tadalafil. Men with renal impairment require dose adjustment: a maximum of 10 mg no more than once every 48 hours is recommended for creatinine clearance 30 to 50 mL/min, per the prescribing information.

A 2021 review published in JAMA found no significant increase in major cardiovascular events with PDE5 inhibitor use in men with stable cardiovascular disease, addressing one of the most common patient concerns about this drug class.

Dosing Options: On-Demand vs. Daily

Tadalafil is the only PDE5 inhibitor with two distinct FDA-approved dosing strategies for ED.

On-Demand Dosing (10 mg or 20 mg)

The starting dose for on-demand use is 10 mg, taken at least 30 minutes before anticipated sexual activity. If response is inadequate, the dose may be increased to 20 mg. The effective window extends to 36 hours, though peak plasma concentration occurs at approximately 2 hours after ingestion. A pharmacokinetic analysis on PubMed confirmed the mean half-life of tadalafil at 17.5 hours, roughly three times longer than sildenafil's 3 to 5 hours, which mechanistically explains the extended window.

Daily Dosing (2.5 mg or 5 mg)

Daily dosing produces steady-state plasma concentrations within 5 days. The approved doses are 2.5 mg and 5 mg once daily, taken at approximately the same time each day without regard to sexual activity. This strategy is particularly suited to men with BPH, since the continuous smooth-muscle relaxation in the prostate and bladder neck reduces lower urinary tract symptoms alongside improving erectile function. The NIH's National Institute of Diabetes and Digestive and Kidney Diseases lists daily tadalafil as an evidence-based option for men with both ED and BPH.

HealthRX Dose-Selection Framework for Tadalafil:

| Patient Profile | Recommended Strategy | Starting Dose | |---|---|---| | Sex fewer than 2x/week, no BPH | On-demand | 10 mg, titrate to 20 mg | | Sex 2x/week or more, no BPH | Daily | 5 mg | | ED plus BPH symptoms | Daily | 5 mg | | BPH only (no ED concern) | Daily | 5 mg | | Renal impairment (CrCl 30 to 50) | On-demand only | 10 mg max, q48h |

This framework reflects FDA prescribing information and AUA guideline recommendations; individual dose decisions require physician assessment.

Side Effects: Clinical Data vs. Real-World Reports

What Trials Reported

The prescribing information lists adverse events from pooled placebo-controlled trial data. Headache occurred in 11 percent of patients on tadalafil 20 mg vs. 5 percent on placebo. Dyspepsia (indigestion) occurred in 10 percent vs. 1 percent. Back pain occurred in 6 percent vs. 1 percent. Myalgia occurred in 5 percent vs. 1 percent. Flushing occurred in 3 percent vs. 1 percent. These figures come from the FDA-approved label, which draws on controlled trial populations.

What Users Actually Report

Real-world reports on Drugs.com and Reddit emphasize back pain and myalgia more than the trial percentages might suggest. This likely reflects two factors: men without clinical trial exclusion criteria (who may be using other medications or have additional comorbidities) and a reporting bias toward unexpected side effects. Headache, by contrast, is somewhat underreported in user reviews relative to trial data, possibly because users expect it more readily.

A PubMed-indexed meta-analysis of tadalafil safety across 42 trials (N=8,022) found serious adverse events were rare and no different from placebo rates. Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported rarely with PDE5 inhibitors, and the FDA label carries a warning; however, causality has not been established, and the FDA's MedWatch data suggest the background rate of NAION in the target demographic may account for the observed reports.

How Tadalafil Compares to Other ED Medications

PDE5 inhibitors approved by the FDA for ED include sildenafil (Viagra), vardenafil (Levitra), avanafil (Stendra), and tadalafil (Cialis). All share the same mechanism but differ in duration, onset, food interactions, and dosing flexibility.

A Cochrane systematic review comparing PDE5 inhibitors for ED found no statistically significant difference in efficacy between agents when measured by IIEF domain scores, but confirmed tadalafil's unique daily-dose option and its longer half-life as pharmacologically distinct features. Avanafil (Stendra) has the fastest onset (15 minutes), but its 6-to-12-hour window is shorter than tadalafil's and it carries a higher price point without a generic equivalent available in the US as of 2025.

Sildenafil (generic Viagra) is now available for as little as $10 to $20 per month for a 30-tablet supply and represents the price-competitive alternative for men who prefer on-demand dosing. Tadalafil's edge remains the duration and the BPH indication, which no other oral PDE5 inhibitor carries as a standalone daily-dose approval.

Getting Tadalafil: Prescription Pathways in 2025

Tadalafil requires a prescription in the United States. Three main access pathways exist.

Primary Care and Urology Offices

A primary care physician or urologist can prescribe tadalafil after a brief history and, in some practices, a testosterone level check. The American Family Physician recommends checking fasting glucose, lipids, and testosterone in men presenting with new ED, since ED can be an early marker of cardiovascular disease and hypogonadism.

Telehealth Platforms

Telehealth platforms now handle the majority of new tadalafil prescriptions in the US. A physician asynchronously reviews a health history questionnaire and, if appropriate, sends a prescription to a local or mail-order pharmacy. Most platforms process prescriptions within 24 hours. Total monthly cost (visit plus medication) typically runs $30 to $90, depending on the platform and dose.

Direct-to-Consumer Pharmacy Programs

GoodRx, Cost Plus Drugs, and NeedyMeds all reduce out-of-pocket costs significantly. Cost Plus Drugs requires no membership and lists tadalafil 5 mg at approximately $12.60 for 30 tablets. GoodRx coupons vary by pharmacy but routinely bring tadalafil 20 mg (6 tablets) below $20 at national chains.